Fibrocell Science, Inc., is an autologous cellular therapeutic company focused on
the development of innovative products for aesthetic, medical and scientific applications. Fibroblasts are responsible for the production of collagen and contribute to the formation of connective tissue fibers. We believe that these cells have a broad application.

Our vision is to develop and bring the value of these unique fibroblast cells to the medical and scientific community. Longer term, we are researching the potential to biotransform autologous dermal fibroblasts to “factor-free” induced pluripotent stem (iPS) cells capable of differentiation into multiple cell types for toxicologic, research, and therapeutic use.